Cover Image

Long noncoding RNAs and metabolic memory associated with continued progression of diabetic retinopathy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jay Kumar, Pooja Malaviya, Renu A. Kowluru
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression profile of circular RNAs in type 2 diabetes mellitus patients with retinopathy
by: Wencheng An, et al.
Published: (2026)

Dysregulation of lncRNA OIP5 ‐ AS1 participants in the progression of diabetic retinopathy and affects the proliferation in retinal vascular endothelial cell
by: Ziwen Yin, et al.
Published: (2025)

Causal association between cystatin C and diabetic retinopathy: A two‐sample Mendelian randomization study
by: Yimeng Ruan, et al.
Published: (2024)

Causal association between circulating leukocyte characteristics and diabetic retinopathy based on two‐sample Mendelian randomization
by: Yan Wang, et al.
Published: (2025)

Fenofibrate shown to reduce progression of diabetic retinopathy
by: Iskandar Idris
Published: (2024)

Methodological considerations in interpreting circRNA profiles in diabetic retinopathy
by: Yindan Song, et al.
Published: (2026)

Retrospective database study on risk factors for diabetic retinopathy and diabetic kidney disease in Japanese patients with diabetes mellitus
by: Kota Yamada, et al.
Published: (2024)

Erythrocyte deformability correlates with microvascular ischemia and disease severity in diabetic retinopathy
by: Ye Eun Han, et al.
Published: (2026)

The cholesterol‐HDL‐glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy
by: Merve Çatak, et al.
Published: (2025)

Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus
by: Ching‐Kit Tsui, et al.
Published: (2025)

Commentary on “Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus”
by: Fatemeh Rasulpur, et al.
Published: (2025)

YY2 mediates transcriptional repression of PHGDH and expedites oxidative stress in retinal pigment epithelial cells in diabetic retinopathy
by: Xiang Lei, et al.
Published: (2025)

Critical methodological concerns regarding the association between metabolic indices and microvascular complications in type 2 diabetes
by: Wenya Han, et al.
Published: (2025)

Semaglutide attenuates diabetic retinopathy progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro
by: Xiao Cheng, et al.
Published: (2025)

Potential mechanisms of metabolic reprogramming induced by ischemia–reperfusion injury in diabetic myocardium
by: Haiping Ma, et al.
Published: (2024)

Ginsenoside Rg1 inhibits angiogenesis in diabetic retinopathy through the miR‐100‐3p/FBXW7/c‐MYC molecular axis
by: Liping Xue, et al.
Published: (2025)

High estradiol/testosterone ratio increased the risk of metabolic dysfunction‐associated steatotic liver disease in men with type 2 diabetes mellitus
by: Meng‐Han Li, et al.
Published: (2025)

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
by: Djordje S. Popovic, et al.
Published: (2024)

Advances in continuous glucose monitoring and their impact on glycemic control in diabetes
by: Yi‐Hsuan Lai, et al.
Published: (2026)

Relationship between the progression of diabetic polyneuropathy and impaired circadian blood pressure variability
by: Dai Yamagami, et al.
Published: (2024)

Increased prevalence of diabetes mellitus and its metabolic risk factors from 2002 to 2017 in Shanghai, China
by: Qinping Yang, et al.
Published: (2024)

Cost‐effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial
by: Graham Scotland, et al.
Published: (2025)

A nomogram incorporating clinical and laboratory indicators for predicting metabolic dysfunction‐associated fatty liver disease in newly diagnosed type 2 diabetes patients
by: Tingting Li, et al.
Published: (2025)

Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures
by: Zachary A. Weber
Published: (2019)

Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose–response meta‐analysis based on animal models
by: Xiaojing Liu, et al.
Published: (2024)

Elevated small dense low‐density lipoprotein cholesterol to high‐density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus
by: Shouxing Yang, et al.
Published: (2024)

miR‐130a‐3p enhances autophagy through the YY1/PI3K/AKT/mTOR signaling pathway to regulate macrophage polarization and alleviate diabetic retinopathy
by: Xiaoting Xi, et al.
Published: (2024)

Metformin continuation post‐metabolic bariatric surgery and relapse of diabetes
by: Dror Dicker, et al.
Published: (2024)

Non‐linear relationship between liver fibrosis and femoral neck bone mineral density in metabolic dysfunction‐associated fatty liver disease patients with type 2 diabetes mellitus
by: Jie Tao, et al.
Published: (2025)

Beyond vision: The emotional toll of advanced diabetic retinopathy response to the letter
by: Hellena Hailu Habte‐Asres, et al.
Published: (2026)

Construction of a metabolic‐immune model for predicting the risk of diabetic nephropathy and study of gut microbiota
by: Mengting Dai, et al.
Published: (2025)

LGR signaling and metabolic regulation: A new frontier in addressing insulin resistance and diabetes treatment
by: Tomohisa Aoyama, et al.
Published: (2025)

High HOMA2‐B: A novel risk factor for diabetic peripheral neuropathy beyond metabolic syndrome components in type 2 diabetes
by: Koichi Kato
Published: (2025)

Comparing Equil patch versus traditional catheter insulin pump in type 2 diabetes using continuous glucose monitoring metrics and profiles
by: Yu‐Jiao Li, et al.
Published: (2024)

Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
by: Scott A. Coon, et al.
Published: (2025)

Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type
by: Roberto Franceschi, et al.
Published: (2024)

Construction and validation of nomogram prediction model for ketoacidosis in elderly diabetic patients based on baseline data and glycolipid metabolism
by: Aijin Niu, et al.
Published: (2025)

Classification of Japanese type 1 diabetes based on clinical phenotypes and its association with diabetic complications: Across‐sectional study
by: Takafumi Masuda, et al.
Published: (2025)

Cholesterol accumulation in monocytes is associated with the severity of diabetic complications and the efficacy of glycemic control interventions in patients with type 2 diabetes
by: Hideyuki Okuma, et al.
Published: (2026)

Obstructive sleep apnoea is associated with accelerated progression of diabetic kidney disease
by: Sebastian Nielsen, et al.
Published: (2026)